uroplasty designs, develops, manufactures and markets medical products used for the treatment of urinary and fecal incontinence, vesicoureteral reflux, vocal cord rehabilitation and soft tissue facial augmentation. macroplastique? an injectable soft tissue bulking agent, is uroplasty? market leader used to treat both female and male urinary incontinence, and to treat vesicoureteral reflux in children. additionally, uroplasty markets soft tissue bulking agents for specific indications such as ptp implants?for the treatment of fecal incontinence, vox implants?for the treatment of vocal cord rehabilitation and bioplastique?implants for augmentation or restoration of soft tissue defects in plastic surgery indications.

Macroplastique Incontinence Reflux Vesicoureteral Vesicoureteric Injectable Sui Vur Stress Incontinence Treatment Male Incontinence Female Incontinence Post-prostatectomy

Minimally Invasive Bulking Agent Urinary Incontinence Urethral Incontinence Therapy Implants Ureteral Orifice Urine Mid-urethra Bladder Neck Transurethral Ptp Mis

Contact:	612-378-1180
Address:	2718 Summer St. N.e. Minneapolis, Minnesota   55413 , USA
Url:	http://www.uroplasty.com
Fax:	612-378-2027
Year Established:	1992
Annual Sales:	US$2.5 Million - US$5 Million